154 related articles for article (PubMed ID: 15203864)
21. Therapeutic implications of the MDR-1 gene.
Mealey KL
J Vet Pharmacol Ther; 2004 Oct; 27(5):257-64. PubMed ID: 15500562
[TBL] [Abstract][Full Text] [Related]
22. Relationship between the C3435T and G2677T(A) polymorphisms in the ABCB1 gene and P-glycoprotein expression in human liver.
Owen A; Goldring C; Morgan P; Chadwick D; Park BK; Pirmohamed M
Br J Clin Pharmacol; 2005 Mar; 59(3):365-70. PubMed ID: 15752383
[TBL] [Abstract][Full Text] [Related]
23. MDR1 gene polymorphisms and risk of gingival hyperplasia induced by calcium antagonists.
Meisel P; Giebel J; Kunert-Keil C; Dazert P; Kroemer HK; Kocher T
Clin Pharmacol Ther; 2006 Jan; 79(1):62-71. PubMed ID: 16413242
[TBL] [Abstract][Full Text] [Related]
24. MDR1 haplotypes modify BEN disease risk: a study in Bulgarian patients with Balkan endemic nephropathy compared to healthy controls.
Atanasova S; von Ahsen N; Dimitrov T; Armstrong V; Oellerich M; Toncheva D
Nephron Exp Nephrol; 2004; 96(1):e7-13. PubMed ID: 14752243
[TBL] [Abstract][Full Text] [Related]
25. MDR1 haplotypes significantly minimize intracellular uptake and transcellular P-gp substrate transport in recombinant LLC-PK1 cells.
Salama NN; Yang Z; Bui T; Ho RJ
J Pharm Sci; 2006 Oct; 95(10):2293-308. PubMed ID: 16883550
[TBL] [Abstract][Full Text] [Related]
26. Novel approaches to reversing anti-cancer drug resistance using gene-specific therapeutics.
Kobayashi H; Takemura Y; Miyachi H
Hum Cell; 2001 Sep; 14(3):172-84. PubMed ID: 11774737
[TBL] [Abstract][Full Text] [Related]
27. Multi-drug resistance-1 gene polymorphisms in nephrotic syndrome: impact on susceptibility and response to steroids.
Youssef DM; Attia TA; El-Shal AS; Abduelometty FA
Gene; 2013 Nov; 530(2):201-7. PubMed ID: 23994685
[TBL] [Abstract][Full Text] [Related]
28. Comparative description of haplotype structure and genetic diversity of MDR1 (ABCB1) in HIV-positive and HIV-negative populations.
Benish RL; Rodriguez B; Zimmerman PA; Mehlotra RK
Infect Genet Evol; 2010 Jan; 10(1):60-7. PubMed ID: 19819348
[TBL] [Abstract][Full Text] [Related]
29. ABCB1/MDR1 gene determines susceptibility and phenotype in ulcerative colitis: discrimination of critical variants using a gene-wide haplotype tagging approach.
Ho GT; Soranzo N; Nimmo ER; Tenesa A; Goldstein DB; Satsangi J
Hum Mol Genet; 2006 Mar; 15(5):797-805. PubMed ID: 16434479
[TBL] [Abstract][Full Text] [Related]
30. MDR1 C3435T polymorphism and cancer risk: a meta-analysis based on 39 case-control studies.
Sheng X; Zhang L; Tong N; Luo D; Wang M; Xu M; Zhang Z
Mol Biol Rep; 2012 Jul; 39(7):7237-49. PubMed ID: 22311042
[TBL] [Abstract][Full Text] [Related]
31. No effect of MDR1 C3435T variant on loperamide disposition and central nervous system effects.
Pauli-Magnus C; Feiner J; Brett C; Lin E; Kroetz DL
Clin Pharmacol Ther; 2003 Nov; 74(5):487-98. PubMed ID: 14586389
[TBL] [Abstract][Full Text] [Related]
32. [Polymorphisms of the multiple drug resistance gene (MDR1) in Mapuche, Mestizo and Maori populations in Chile].
Wielandt AM; Vollrath V; Chianale J
Rev Med Chil; 2004 Sep; 132(9):1061-8. PubMed ID: 15543762
[TBL] [Abstract][Full Text] [Related]
33. Lack of association between the C3435T polymorphism in the human multidrug resistance (MDR1) gene and response to antiepileptic drug treatment.
Sills GJ; Mohanraj R; Butler E; McCrindle S; Collier L; Wilson EA; Brodie MJ
Epilepsia; 2005 May; 46(5):643-7. PubMed ID: 15857428
[TBL] [Abstract][Full Text] [Related]
34. MDR1 gene polymorphisms may be associated with Behçet's disease and its colchicum treatment response.
Rustemoglu A; Gül Ü; Gümüş-Akay G; Gönül M; Yiğit S; Bozkurt N; Karadağ A; Pişkin E; Sunguroğlu A; Kadıkıran A
Gene; 2012 Sep; 505(2):333-9. PubMed ID: 22705826
[TBL] [Abstract][Full Text] [Related]
35. Emerging new technologies in Pharmacogenomics: rapid SNP detection, molecular dynamic simulation, and QSAR analysis methods to validate clinically important genetic variants of human ABC Transporter ABCB1 (P-gp/MDR1).
Ishikawa T; Sakurai A; Hirano H; Lezhava A; Sakurai M; Hayashizaki Y
Pharmacol Ther; 2010 Apr; 126(1):69-81. PubMed ID: 20138191
[TBL] [Abstract][Full Text] [Related]
36. Induction of multidrug resistance in MOLT-4 cells by anticancer agents is closely related to increased expression of functional P-glycoprotein and MDR1 mRNA.
Liu ZL; Onda K; Tanaka S; Toma T; Hirano T; Oka K
Cancer Chemother Pharmacol; 2002 May; 49(5):391-7. PubMed ID: 11976833
[TBL] [Abstract][Full Text] [Related]
37. Influence of adenosine triphosphate and ABCB1 (MDR1) genotype on the P-glycoprotein-dependent transfer of saquinavir in the dually perfused human placenta.
Rahi M; Heikkinen T; Hakkola J; Hakala K; Wallerman O; Wadelius M; Wadelius C; Laine K
Hum Exp Toxicol; 2008 Jan; 27(1):65-71. PubMed ID: 18480151
[TBL] [Abstract][Full Text] [Related]
38. Association of MDR1 C3435T polymorphism with bipolar disorder in patients treated with valproic acid.
Turgut G; Kurt E; Sengul C; Alatas G; Kursunluoglu R; Oral T; Turgut S; Herken H
Mol Biol Rep; 2009 Mar; 36(3):495-9. PubMed ID: 18165917
[TBL] [Abstract][Full Text] [Related]
39. Pharmacogenetics of MDR1 and its impact on the pharmacokinetics and pharmacodynamics of drugs.
Sakaeda T; Nakamura T; Okumura K
Pharmacogenomics; 2003 Jul; 4(4):397-410. PubMed ID: 12831320
[TBL] [Abstract][Full Text] [Related]
40. The role of MDR1 genetic polymorphisms in interindividual variability in P-glycoprotein expression and function.
Woodahl EL; Ho RJ
Curr Drug Metab; 2004 Feb; 5(1):11-9. PubMed ID: 14965248
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
